300434.SZ
Price:
$9.04
Market Cap:
$3.63B
Sichuan Goldstone Asia Pharmaceutical Inc. engages in the research, development, manufacture, and sale of medicines and health products in China and internationally. The company offers various pharmaceutical preparations and APIs; Chinese and western pharmaceutical preparations and raw materials; and tablets, capsules, dietary supplements, vitamin products, OTC products, and prescription drugs. It also trades in various pharmaceutical products, such as Chinese herbal medicine materials, Chinese patent medicines, Chinese herbal pieces, chemical raw materials, pharmaceutical preparations, antibiotic preparations, biochemical drugs, dietary supplements, and toxic drugs for medical use, medical ...[Read more]
Industry
Industrial - Distribution
IPO Date
2015-04-30
Stock Exchange
SHZ
Ticker
300434.SZ
According to Sichuan Goldstone Asia Pharmaceutical Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 56.50. This represents a change of 221.48% compared to the average of 17.57 of the last 4 quarters.
The mean historical PE Ratio of Sichuan Goldstone Asia Pharmaceutical Inc. over the last ten years is 59.93. The current 56.50 PE Ratio has changed 9.33% with respect to the historical average. Over the past ten years (40 quarters), 300434.SZ's PE Ratio was at its highest in in the June 2018 quarter at 904.93. The PE Ratio was at its lowest in in the June 2019 quarter at -2694.39.
Average
59.93
Median
35.77
Minimum
-4.46
Maximum
183.69
Discovering the peaks and valleys of Sichuan Goldstone Asia Pharmaceutical Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 613.30%
Maximum Annual PE Ratio = 183.69
Minimum Annual Increase = -1572.25%
Minimum Annual PE Ratio = -4.46
Year | PE Ratio | Change |
---|---|---|
2024 | 35.87 | 0.54% |
2023 | 35.68 | 42.76% |
2022 | 24.99 | -61.92% |
2021 | 65.63 | -1572.25% |
2020 | -4.46 | -117.45% |
2019 | 25.54 | 7.63% |
2018 | 23.73 | -34.42% |
2017 | 36.18 | -80.30% |
2016 | 183.69 | 6.54% |
2015 | 172.42 | 613.30% |
The current PE Ratio of Sichuan Goldstone Asia Pharmaceutical Inc. (300434.SZ) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
32.18
5-year avg
31.54
10-year avg
59.93
Sichuan Goldstone Asia Pharmaceutical Inc.’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sichuan Goldstone Asia Pharmaceutical Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sichuan Goldstone Asia Pharmaceutical Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Sichuan Goldstone Asia Pharmaceutical Inc.'s PE Ratio?
How is the PE Ratio calculated for Sichuan Goldstone Asia Pharmaceutical Inc. (300434.SZ)?
What is the highest PE Ratio for Sichuan Goldstone Asia Pharmaceutical Inc. (300434.SZ)?
What is the 3-year average PE Ratio for Sichuan Goldstone Asia Pharmaceutical Inc. (300434.SZ)?
What is the 5-year average PE Ratio for Sichuan Goldstone Asia Pharmaceutical Inc. (300434.SZ)?
How does the current PE Ratio for Sichuan Goldstone Asia Pharmaceutical Inc. (300434.SZ) compare to its historical average?